|
Product Details:
|
| Place Of Origin: | China (Mainland) | Brand Name: | BBCA |
|---|---|---|---|
| Other Names: | Pharmaceutical Grade Cilnidipine Tablets | Grade: | Medicine Grade |
| Dosage Form: | Injection | ||
| High Light: | cardiovascular medicine,naftopidil tablets |
||
Pharmaceutical Grade Cilnidipine Tablets Dual L-/N-Type Calcium Channel Protein Inhibitor And Blocker
Specifications
Cilnidipine is a dual L-/N-type calcium channel protein inhibitor and blocker. Cilnidipine has displayed renal and vascular protective effects and improved baroreflex sensitivity in patients with hypertension. It has also demonstrated neuroprotective effects in a rat focal brain ischemia model by removing free radicals and activating the phosphatidylinositol 3-kinase pathway.
Cilnidipine Tablets
Type: Calcium Antagonists
Usage: Treatment for hypertension patients
Packing: 14TabletsX100Boxes/Carton
GMP Certified
Standard: 10mg
Original: China
Manufacture: ANHUI BBCA PHARMRACEUTICAL Co., Ltd.
Hypersensitivity to Cilnidipine Tablet is a contraindication. In addition, Cilnidipine Tablet should not be used if you have the following conditions:
Acute myocardial infarction
Cardiac ischemia
Preexisting heart conditions
Unstable angina
Contact Person: Channing
Tel: +8618755119229
